CDH1 and breast cancer: In the case of aggressive breast cancer cells, namely triple-negative cancer, the knockdown of β-cantenin induces a reverse-effect following the reduction of E-cadherin expression levels leading to increased cell motility and epithelial to mesenchymal transition as the study of Cai et al. showed [37].